Park, H., Garrido-Laguna, I., Naing, A., Fu, S., Falchook, G. S., Piha-Paul, S. A., . . . Janku, F. (2016). Phase I dose-escalation study of the mTOR inhibitor sirolimus and the HDAC inhibitor vorinostat in patients with advanced malignancy. Oncotarget.
Citação norma ChicagoPark, Haeseong, et al. "Phase I Dose-escalation Study of the MTOR Inhibitor Sirolimus and the HDAC Inhibitor Vorinostat in Patients With Advanced Malignancy." Oncotarget 2016.
Citação norma MLAPark, Haeseong, et al. "Phase I Dose-escalation Study of the MTOR Inhibitor Sirolimus and the HDAC Inhibitor Vorinostat in Patients With Advanced Malignancy." Oncotarget 2016.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.